BARCLAYS PLC - TALARIS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50
+138.1%
17,696
+151.0%
0.00%
Q2 2023$21
-40.0%
7,049
-62.4%
0.00%
Q1 2023$35
+169.2%
18,760
+41.7%
0.00%
Q4 2022$13
-99.9%
13,242
+65.0%
0.00%
Q3 2022$22,000
-40.5%
8,027
-1.8%
0.00%
Q2 2022$37,000
-67.5%
8,174
-29.4%
0.00%
Q1 2022$114,00011,5800.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$28,857,00027.11%
Aisling Capital Management LP 682,923$6,720,0003.63%
Cormorant Asset Management, LP 1,174,723$11,559,0000.89%
Artal Group S.A. 2,064,262$20,312,0000.85%
SECTORAL ASSET MANAGEMENT INC 228,624$2,250,0000.40%
Logos Global Management LP 306,236$3,013,0000.39%
Eventide Asset Management 1,561,092$15,361,0000.24%
Blackstone Inc. 8,089,315$79,599,0000.20%
HHLR ADVISORS, LTD. 698,797$6,876,0000.14%
VIKING GLOBAL INVESTORS LP 3,289,617$32,370,0000.13%
View complete list of TALARIS THERAPEUTICS INC shareholders